Publications

Patents filed (2)

1. “Alpha terpinene as a novel permeation enhancer’, patent No. IN201001998-I1.
2. “Sabinene hydrate as a novel permeation enhancer”. Patent No. IN201001999-I1.

Book/Chapter Published (3)

1.  Aqil M, Ahad A, Sultana Y. Laboratory manual of hospital pharmacy (2010). Birla Publications Pvt. Ltd., Delhi. Book ID: EBK0246775, ISBN-9798189747809
2. Ahad A and Aqil M. (2012-10). Surgical Instruments, Hospital Equipments and Health Accessories. In: Aqil M. Practice of Hospital, Clinical and Community Pharmacy. India: Elsevier Health Sciences. p84-102.
3. Ahad A and Aqil M. (2012-10). Code of Ethics for Pharmacists. In: Aqil M. Practice of Hospital, Clinical and Community Pharmacy. India: Elsevier Health Sciences. p424-435.

Papers published (32)

1. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. Nano vesicular lipid carriers of angiotensin II receptor blocker: Anti-hypertensive and skin toxicity study in focus. Artif Cells Nanomed Biotechnol. 2015. (Impact factor. 0.710)
2. Ali A, Kumar N, Ahad A, Aqil M, Sultana Y. Enhanced delivery of diclofenac diethylamine loaded Eudragit RL100® transdermal system against inflammation. J Polym Eng. 2015 (Impact factor -0.5)
3. AL-Mohizea A M, Ahad A, Raish M, AL-Jenoobi F I, Alam, M A. Improved oral bioavailability of theophylline, a narrow therapeutic index drug by ginger. Lat Am J Pharm. 2015. (Impact factor. 0.319)
4. Al-Jenoobi FI, Korashy HM, Ahad A, Raish M, Al-Mohizea AM,  Alam MA, Al-Suwayeh SA, Alkharfy KM. Investigating the potential inhibitory effect of herbal medicines on rat hepatic cytochrome P450 2D gene expression and metabolic activity. Pharmazie 2014; 69(11) pp. 799-803. (Impact factor. 1.003)
5. Al-Jenoobi FI, Ahad A, Mahrous GM, Al-Mohizea AM, Alkharfy KM, Al-Suwayeh SA. Effects of fenugreek, garden cress, and black seed on theophylline pharmacokinetics in beagle dogs. Pharmaceutical Biology 2014 Sep 22:1-5. (Impact factor. 1.337)
6. Vashisth I, Ahad A, Aqil M, Agarwal SP. Investigating the potential of essential oils as penetration enhancer for transdermal losartan delivery: Effectiveness and mechanism of action. Asian J Pharm Sci. 2014; 9(5): 260–267.
7. Korashy HM, Al-Jenoobi FI, Raish M, Ahad A, Al-Mohizea AM, Alam MA, Alkharfy KM, Al-Suwayeh SA. Impact of herbal medicines like nigella sativa, trigonella foenum-graecum, and ferula asafoetida, on cytochrome P450 2C11 gene expression in rat liver. Drug Res (Stuttg). 2014 Aug 6. (Impact factor. 0.507)
8. Ahad A, Al-Mohizea AM, Al-Jenoobi FI, Aqil M. Transdermal delivery of angiotensin II receptor blockers (ARBs), angiotensin-converting enzyme inhibitors (ACEIs) and others for management of hypertension. Drug Deliv. 2014 Jul 28:1-12. (Impact factor. 2.202)
9. Al-Jenoobi FI, Ahad A, Raish M, Al-Mohizea AM, Alam MA.  Investigating the potential effect of Commiphora myrrha on the pharmacokinetics of theophylline, a narrow therapeutic index drug. Drug Research 2014, July 3. (Impact factor. 0.507)
10. AL-Mohizea AM, Ahad A, Ahmed MO, EL-Badry M & Abdel-Rahman AA. Comparative study on the effect of natural cyclodextrins and surfactants on the solubility of isoxsuprine hydrochloride.  Lat Am J Pharm. 2014 33 (5): 766-770. (Impact factor. 0.319)
11. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats. Expert Opin Drug Deliv. 2014 15: 1-14. (Impact factor. 4.11)
12. Al-Mohizea AM, Ahad A, El-Maghraby GM, Al-Jenoobi FI, Alkharfy KM, Al-Suwayeh SA. Effects of Nigella sativa, Lepidium sativum and Trigonella foenum-graecum on sildenafil disposition in beagle dogs. Eur J Drug Metab Pharmacokinet. 2014 Apr 11. (Impact factor. 1.312)
13. Ahad A, Raish M, Al-Mohizea AM, Al-Jenoobi FI, Alam MA. Enhanced anti-inflammatory activity of carbopol loaded meloxicam nanoethosomes gel. Int J Biol Macromol. 2014; 67C: 99-104. (Impact factor. 3.096)
14. Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Akhtar N, Raish M, Aqil M. Systemic delivery of β-blockers via transdermal route for hypertension. Saudi Pharmaceutical Journal. 2014. (Impact factor 1.00)
15. Ahad A, Aqil M, Ali A. Investigation of antihypertensive activity of carbopol valsartan transdermal gel containing 1,8-cineole. Int J Biol Macromol. 2014; 64: 144-149. (Impact factor. 3.096)
16. Al-Jenoobi FI, Alam MA, Alkharfy KM, Al-Suwayeh SA, Korashy HM, Al-Mohizea AM, Iqbal M, Ahad A, Raish M. Pharmacokinetic interaction studies of fenugreek with CYP3A substrates cyclosporine and carbamazepine. Eur J Drug Metab Pharmacokinet. 2013. (Impact factor. 1.312)
17. Al-Jenoobi FI, Al-Suwayeh SA, Muzaffar I, Alam MA, Al-Kharfy KM, Korashy HM, Al-Mohizea AM, Ahad A, Raish M. Effects of Nigella sativa and Lepidium sativum on Cyclosporine Pharmacokinetics. Biomed Res Int. 2013 (Impact factor. 2.707).
18. Ahad A, Al-Jenoobi FI, Al-Mohizea AM, Aqil M, Kohli K. Transdermal delivery of calcium channel blockers for hypertension. Expert Opin Drug Deliv. 2013; 10(8):1137-1153 (Impact factor. 4.11).
19. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. Enhanced transdermal delivery of an anti-hypertensive agent via nanoethosomes:  Statistical optimization, characterization and pharmacokinetic assessment. International journal of Pharmaceutics. 2013; 443: 26-38. (Impact factor.3.785).
20. Imam S, Ahad A, Aqil M, Sultana Y and Ali A. A validated RP-HPLC method for simultaneous determination of propranolol and valsartan in bulk drug and gel formulation. Journal of Pharmacy and Bio Allied Sciences. 2013; 5: 61-65.
21. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M and Asgar Ali. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomedicine: Nanotechnology, Biology, and Medicine. 2012; 8: 237–249. (Impact factor. 5.978)
22. Akhtar N, Ahad A, Khar RK, Jaggi M, Aqil M, Iqbal Z, Ahmad FJ & Talegaonkar S. Emerging role of P-Glycoprotein inhibitors in drug delivery: A patent review. Expert Opinion on Therapeutic Patents. 2011; 21(4):561-576. (Impact factor- 3.441)
23. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. Role of novel terpenes in transcutaneous permeation of valsartan: Effectiveness and mechanism of action. Drug Development and Industrial Pharmacy. 2011; 37(5):583-596.  (Impact factor- 2.006)
24. Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M. Interactions between novel terpenes and main components of rat and human skin: Mechanistic view for transdermal delivery of propranolol hydrochloride. Current Drug Delivery. 2011;8(2):213-224. (Impact factor- 2.248)
25. Ahad, M. Aqil, K. Kohli, Y. Sultana, M. Mujeeb. Transdermal drug delivery: the inherent challenges and technological advancements. Asian Journal of Pharmaceutical Sciences. 2010; 5 (5): 214-227.
26. Hassan N, Ahad A, Ali M & Ali J. Chemical permeation enhancers for transbuccal drug delivery. Expert Opinion on Drug Delivery. 2010; 7(1):97-112 (Impact Factor- 4.11)
27. Ahad A, Aqil M, Kohli K, Chaudhary H, Sultana Y, Mujeeb M, Talegaonkar S. Chemical penetration enhancers: a patent review. Expert Opinion on Thererapeutic Patents. 2009;19 (7), 969-88. (Impact factor- 3.441)
28. Jain R, Aqil M, Ahad A, Ali A, Khar RK. Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride. Drug Development and Industrial Pharmacy.  2008; 34 (4):384-389. (Impact factor- 2.00)
29. Rizwan M, Aqil M, Ahad A, Sultana Y, Ali MM. Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Development and Industrial Pharmacy 2008; 34(6):618-626. (Impact factor- 2.00)
30. Aqil M, Ali A, Ahad A, Sultana Y, Najmi Ak, Saha N. A validated method for estimation of metoprolol in human plasma by high performance liquid chromatography. Acta Chromatographica. 2007; 19: 130-140. (Impact factor- 0.485)
31. Zafar S, Ali A, Aqil M, Sultana Y, Ahad A. Transdermal delivery of labetalol hydrochloride: Effect of penetration enhancers. Journal of Pharmacy and Bioallied Sciences. 2010; 2(4): 321-324.
32. Aqil M, Ahad A, Sultana Y, Ali A. Status of terpenes as skin penetration enhancers. Drug Discov Today. 2007; 12(23-24):1061-1067. (Impact factor- 5.964)

Papers Presented/Abstracted (7)

1. Ahad A, Aqil M, Alam SM, Kohli K, Sultana Y, Mujeeb M, Najmi AK, Akhtar M, Ismail MV, Ali A. Skin Permeation Enhancement Of An Antihypertensive Drug By Novel Terpenes. National Seminar On Lifestyle Disorders And Role Of Unani Medicine. 6th March, 2012. Faculty of Unani Medicine, Jamia Hamdard, Hamdard Nagar, New Delhi - 110062.
2. Aqil M, Ahad A, Kohli K, Sultana Y, Mujeeb M, Najmi AK, Akhtar M, Ali A. Accentuated Transdermal Delivery of Valsartan By Eucalyptol. National seminar on “Recent Trends in Drug Discovery & Development”. March 26, 2011. B.S. Anangpuria, Village Alampur, Ballabgarh-Sohna Road, Faridabad-121004
3. Ahad A, Aqil M, Kohli K, Ali A. Enantiomeric Effects of Iso-Eucalyptol and Eucalyptol on Transdermal Delivery of Propranolol. IPC- 2010, Manipal.
4. Ahad A, Aqil M, Kohli K, Sultana Y and Mujeeb M. Skin permeation mechanism of valsartan from transdermally applied gel formulation using 1, 8-cineole as permeation enhancer. British Pharmaceutical conference, Manchester, UK. Published in Journal of Pharmacy and Pharmacology 2009; Supplement 1
5. Ahad A, Aqil M, Kohli K, Sultana Y and Mujeeb M Effect of eugenol on transdermal delivery of valsartan: a mechanistic study, Proceedings of National Seminar on Emerging Trends in Pharmaceutical Sciences, Jamia Hamdard, New Delhi 21-22 March 2009.
6. Ahad A, Aqil M, Kohli K, Sultana Y. Comparative effects of Eucalyptol and Iso-Eucalyptol on transdermal delivery of valsartan. IPC-2009, Ahmedabad.
7. Ahad A, Aqil M, Kohli K, Sultana Y and Mujeeb M. Effect of various terpenes on transdermal delivery of valsartan and in vivo antihypertensive activity of transdermal gel in IPC. 2007